Camad, Baina C.
HRN: 28-94-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2026
AMPICILLIN 250MG (VIAL)
04/29/2026
05/06/2026
IV
150 Mg
Q 6 Hours
Bacterial Skin Infection
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: